Hummingbird Study: Results from an Exploratory Trial Assessing the Performance and Acceptance of a Digital Medicine System in Adults with Schizophrenia, Schizoaffective Disorder, or First-Episode Psychosis.

Fowler, J Corey; Cope, Nathan; Knights, Jonathan; Fang, Hui; Skubiak, Taisa; Shergill, Sukhi S; Phiri, Peter; Rathod, Shanaya; Peters-Strickland, Timothy

Fowler, J Corey; Cope, Nathan; Knights, Jonathan; Fang, Hui; Skubiak, Taisa; Shergill, Sukhi S; Phiri, Peter; Rathod, Shanaya; Peters-Strickland, Timothy.

Afiliação

Fowler JC; Global Clinical Development, CNS and Digital Medicine, Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, NJ, 08540, USA.
Cope N; Program Management, Otsuka Pharmaceutical Europe Ltd., Wexham, SL3 6PJ, UK.
Knights J; Data Insights and Analytics, Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, NJ, 08540, USA.
Fang H; Biostatistics, Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, NJ, 08540, USA.
Skubiak T; Clinical Management, Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, NJ, 08540, USA.
Shergill SS; Institute of Psychiatry, Psychology and Neuroscience, King's College London and South London and Maudsley NHS Foundation Trust, London, SE5 8AF, UK.
Phiri P; Southern Health NHS Foundation Trust, Moorgreen Hospital, Clinical Trials Facility, Research Department, Southampton, SO30 3JB, UK.
Rathod S; Southern Health NHS Foundation Trust, Moorgreen Hospital, Clinical Trials Facility, Research Department, Southampton, SO30 3JB, UK.
Peters-Strickland T; Global Clinical Development, CNS and Digital Medicine, Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, NJ, 08540, USA.